ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
arcsarx
|
163 |
61K |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
163
|
61K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
12 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
22K
|
11M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
5 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
22K
|
11M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
52 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
22K
|
11M
|
52
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
14 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
13K
|
6.2M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
12 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
22K
|
11M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
11 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
22K
|
11M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
arcsarx
|
315 |
144K |
22 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
144K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
arcsarx
|
315 |
144K |
24 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
144K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
12 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
13K
|
6.2M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present at J.P. Morgan Healthcare Conference
|
|
arcsarx
|
187 |
86K |
1 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
187
|
86K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Hervaxx Trials
|
|
arcsarx
|
63 |
40K |
28 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
63
|
40K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene onCARlytics with Celularity CyCART-19 T Cells SITC
|
|
arcsarx
|
66 |
38K |
10 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
66
|
38K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
18 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
13K
|
6.2M
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Hmm interesting... Very very interesting... Time to buy?
|
|
arcsarx
|
435 |
245K |
58 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
435
|
245K
|
58
|
|
ASX - By Stock
|
IMU |
Re:
Competition for IMU?
|
|
arcsarx
|
29 |
18K |
3 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
29
|
18K
|
3
|
|
Charts
|
IMU |
Re:
Anyone else frustrated with the SP with all the positive news we have received lately?
|
|
arcsarx
|
263 |
129K |
9 |
09/01/22 |
09/01/22 |
Charts
|
263
|
129K
|
9
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
arcsarx
|
31K |
15M |
10 |
11/12/21 |
11/12/21 |
Charts
|
31K
|
15M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration
|
|
arcsarx
|
60 |
39K |
17 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
60
|
39K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
arcsarx
|
1.0K |
357K |
7 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
1.0K
|
357K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus for SPP and Placement Options Offer
|
|
arcsarx
|
198 |
102K |
3 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
198
|
102K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
2 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
13K
|
6.2M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Research partnership with Celularity for solid tumors
|
|
arcsarx
|
178 |
82K |
3 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
178
|
82K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Research partnership with Celularity for solid tumors
|
|
arcsarx
|
178 |
82K |
0 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
178
|
82K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Research partnership with Celularity for solid tumors
|
|
arcsarx
|
178 |
82K |
3 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
178
|
82K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at NWR virtual investor conference
|
|
arcsarx
|
153 |
60K |
26 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
153
|
60K
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
20 |
18/07/21 |
18/07/21 |
ASX - By Stock
|
13K
|
6.2M
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
arcsarx
|
246 |
135K |
23 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
135K
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
12 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
13K
|
6.2M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
23 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
22K
|
11M
|
23
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
|
|
arcsarx
|
191 |
58K |
15 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
191
|
58K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
arcsarx
|
13K |
6.2M |
6 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
19 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
22K
|
11M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
54 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
22K
|
11M
|
54
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
arcsarx
|
3.1K |
1.0M |
2 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
3.1K
|
1.0M
|
2
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
arcsarx
|
3.1K |
1.0M |
0 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
3.1K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMU Medicine |
Re:
Monetising IMU
|
|
arcsarx
|
76 |
48K |
57 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
76
|
48K
|
57
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Presentation
|
|
arcsarx
|
101 |
41K |
11 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
101
|
41K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS
|
|
arcsarx
|
346 |
179K |
31 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
346
|
179K
|
31
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
arcsarx
|
31K |
15M |
11 |
14/05/21 |
14/05/21 |
Charts
|
31K
|
15M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
arcsarx
|
22K |
11M |
9 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
22K
|
11M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM
|
|
arcsarx
|
112 |
71K |
3 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
112
|
71K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM
|
|
arcsarx
|
112 |
71K |
25 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
112
|
71K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM
|
|
arcsarx
|
112 |
71K |
22 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
112
|
71K
|
22
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Successful Completion of First Patient Cohort Phase 1 Trial
|
|
arcsarx
|
36 |
10K |
7 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
36
|
10K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
arcsarx
|
214 |
111K |
17 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
214
|
111K
|
17
|
|
ASX - By Stock
|
IMU Biotech |
Re:
A Partnership Deal or Buyout for Imugene?
|
|
arcsarx
|
101 |
58K |
6 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
101
|
58K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
todays close
|
|
arcsarx
|
28 |
9.4K |
5 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
28
|
9.4K
|
5
|
|
ASX - By Stock
|
IMU Biotech |
Re:
A Partnership Deal or Buyout for Imugene?
|
|
arcsarx
|
101 |
58K |
31 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
101
|
58K
|
31
|
|
ASX - By Stock
|
IMU Biotech |
Re:
A Partnership Deal or Buyout for Imugene?
|
|
arcsarx
|
101 |
58K |
47 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
101
|
58K
|
47
|
|